PDL BioPharma
engages in intellectual property asset management and patent portfolio and related assets investment activities... Read morePDL BioPharma
engages in intellectual property asset management and patent portfolio and related assets investment activities... Read more
News
Aug 21, 2023
Premier Guitar
PDL BioPharma: The Private Stock John McLaughlin Limited Edition from PRS Guitars
Jul 18, 2023
Premier Guitar
PDL BioPharma: PRS Guitars Announces Private Stock John McLaughlin Signature
Dec 14, 2020
BioSpace
PDL BioPharma: PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat
Dec 09, 2020
Seeking Alpha
PDL BioPharma: PDL BioPharma indicates timeline for Nasdaq voluntarily delisting
Dec 04, 2020
Seeking Alpha
PDL BioPharma: PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity
Nov 11, 2020
Seeking Alpha
PDL BioPharma: PDL BioPharma reports Q3 results
Nov 06, 2020
Markets Insider
PDL BioPharma: PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update | Markets Insider
Oct 29, 2020
PR Newswire
Press Release: PDL BioPharma : PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020
Oct 16, 2020
Zacks
PDL BioPharma: PDL BioPharma Enters Oversold Territory
Oct 07, 2020
Optics
PDL BioPharma: PDL BioPharma completes spin-off of Lensar
PDL BioPharma Competitors
1
2
3
4
5
6
7
8
9
10